Y-Intercept (Hong Kong) Ltd

Position in ILMN — Illumina, Inc.

CIK 1772875 HONG KONG, K3

Position in ILMN

as of Jun 30, 2026 · filed Jul 14, 2026 Compact

Position Value

$3,280,108

+$3,031,000 QoQ

Shares Held

18,655

+823.1% QoQ

Ownership

0.012%

of shares outstanding

% of Portfolio

0.07%

of 13F equity value

Holder Rank

#13

of 98 holders

Holding Since

Mar 2021

13 quarters on record

Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Healthcare · as of Jun 30, 2026

Y-Intercept (Hong Kong) Ltd holds $30,838,073 across 12 Diagnostics & Research names. ILMN ranks #3 (10.6% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	IDXX	Idexx Laboratories Inc /De	16,330	$8,596,765
2	GH	Guardant Health, Inc.	52,547	$7,883,626
3	ILMN	Illumina, Inc. This page	18,655	$3,280,108
4	ADPT	Adaptive Biotechnologies Corp	135,137	$2,898,688
5	IQV	Iqvia Holdings Inc.	10,950	$2,115,759
6	WGS	GeneDx Holdings Corp.	27,521	$1,889,316
7	TMO	Thermo Fisher Scientific Inc.	2,669	$1,338,129
8	LH	Labcorp Holdings Inc.	4,074	$1,140,720

13 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$3,280,108	18,655	+823.1%	Shares	Sole	2026-07-14
2026-03-31	$249,108	2,021	-78.3%	Shares	Sole	2026-04-27
2025-12-31	$1,222,017	9,317	-12.2%	Shares	Sole	2026-02-13
2025-09-30	$1,007,441	10,608	-58.0%	Shares	Sole	2025-10-31
2025-06-30	$2,409,579	25,255	+50.7%	Shares	Sole	2025-08-01
2025-03-31	$1,329,341	16,755	-13.2%	Shares	Sole	2025-05-06
2024-12-31	$2,579,059	19,300	+506.0%	Shares	Sole	2025-02-04
2024-09-30	$415,355	3,185	-96.0%	Shares	Sole	2024-11-15
2024-06-30	$8,275,142	79,279	+561.4%	Shares	Sole	2024-08-14
2024-03-31	$1,601,087	11,986	-59.1%	Shares	Sole	2024-05-10
2022-06-30	$5,251,031	29,280	+397.9%	Shares	Sole	2022-08-08
2021-09-30	$2,320,420	5,881	-4.5%	Shares	Sole	2021-11-15
2021-03-31	$2,300,623	6,158	—	Shares	Sole	2021-05-12
No filing history on record for this holder in this stock.